Qiagen N.V. (QGEN) Social Stream
QIAGEN NV (QGEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering QGEN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 6 | $60 | $47.5 | $55.005 | $40.11 | 37.14% |
| 2021-12-14 | 7 | $60 | $47.5 | $55.718 | $40.11 | 38.91% |
| 2022-02-09 | 7 | $60 | $47.5 | $55.005 | $40.11 | 37.14% |
| 2022-02-10 | 7 | $62 | $47.5 | $56.004 | $40.11 | 39.63% |
| 2022-04-04 | 7 | $62.001 | $47.5 | $56.004 | $40.11 | 39.63% |
| 2022-04-28 | 7 | $62.001 | $47.5 | $55.147 | $40.11 | 37.49% |
| 2022-05-02 | 7 | $60 | $47.5 | $53.861 | $40.11 | 34.28% |
| 2022-07-19 | 6 | $60 | $51 | $56 | $40.11 | 39.62% |
| 2022-07-29 | 7 | $60 | $51 | $56 | $40.11 | 39.62% |
| 2022-10-17 | 6 | $60 | $42.5 | $54.416 | $40.11 | 35.67% |
| 2022-10-18 | 7 | $60 | $42.5 | $54.416 | $40.11 | 35.67% |
| 2022-11-09 | 7 | $60 | $42.5 | $54.416 | $40.11 | 35.67% |
| 2022-11-10 | 8 | $60 | $42.5 | $53.785 | $40.11 | 34.09% |
| 2023-02-08 | 7 | $55 | $42.5 | $52.75 | $40.11 | 31.51% |
| 2023-02-10 | 8 | $55 | $42.5 | $52.75 | $40.11 | 31.51% |
| 2023-02-22 | 8 | $60 | $42.5 | $54.071 | $40.11 | 34.81% |
| 2023-05-08 | 9 | $62 | $42.5 | $55.062 | $40.11 | 37.28% |
| 2023-06-21 | 9 | $62 | $42.5 | $54.187 | $40.11 | 35.1% |
| 2023-07-26 | 9 | $62 | $42.5 | $54.062 | $40.11 | 34.78% |
| 2023-08-08 | 9 | $62 | $50 | $55.714 | $40.11 | 38.9% |
| 2023-08-09 | 9 | $62 | $50 | $55.857 | $40.11 | 39.26% |
| 2023-08-11 | 10 | $62 | $48 | $55.571 | $40.11 | 38.55% |
| 2023-09-13 | 10 | $60 | $48 | $53.75 | $40.11 | 34.01% |
| 2023-09-18 | 11 | $60 | $48 | $53.333 | $40.11 | 32.97% |
The Trend in the Analyst Price Target
QGEN's average price target has moved up $0.58 over the prior 36 weeks.
QGEN reports an average of 19.59% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-09 | 7 | 60 | 42.5 | 53.785 | 44.50 | 20.87% |
| 2023-01-06 | 7 | 55 | 42.5 | 52.750 | 50.00 | 5.5% |
| 2023-02-10 | 8 | 55 | 42.5 | 52.750 | 49.21 | 7.19% |
| 2023-06-21 | 9 | 62 | 42.5 | 54.187 | 45.16 | 19.99% |
| 2023-08-15 | 10 | 60 | 48.0 | 53.750 | 43.84 | 22.6% |
QGEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.09 | 5 | 0 | 6 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
QGEN's average broker recommendation rating improved by 0.23 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- QGEN has a lower variance in analysts' estimates than -288.92% of Pharmaceutical Products stocks.
- QIAGEN NV's number of analysts covering the stock is higher than 439.88% of stocks in the large market cap category.
- QIAGEN NV's upside potential (average analyst target price relative to current price) is higher than 640.41% of Pharmaceutical Products stocks.
- In terms of how QIAGEN NV fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 1945.18% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to QIAGEN NV are BLUE, SGEN, and NVAX.
View All Top Stocks by Price Target
Make investment decisions regarding QGEN using the data that counts. Try POWR Ratings for free.